Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas

  • Authors:
    • Jaime Torres
    • Paul L. Regan
    • Robby Edo
    • Payton Leonhardt
    • Eric I. Jeng
    • Eric F. Rappaport
    • Naohiko Ikegaki
    • Xao X. Tang
  • View Affiliations

  • Published online on: October 1, 2010     https://doi.org/10.3892/ijo_00000749
  • Pages: 983-991
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Neuroblastoma is a childhood malignancy of the sympathetic nervous system. The tumor exhibits two different phenotypes: favorable and unfavorable. MYCN amplification is associated with rapid tumor progression and the worst neuroblastoma disease outcome. We have previously reported that inhibitors of histone deacetylase (HDAC) and proteasome enhance favorable neuroblastoma gene expression in neuroblastoma cell lines and inhibit growth of these cells. In this study, we investigated the effect of Trichostatin A or TSA (an HDAC inhibitor), and Epoxomycin (a proteasome inhibitor) on MYCN and p53 expression in MYCN-amplified neuroblastoma cells. It was found that TSA down-regulated MYCN expression, but Epoxomycin and the TSA/Epoxomycin combination led to MYCN hyper-expression in MYCN-amplified neuroblastoma cell lines. Despite their contrasting effects on MYCN expression, TSA and Epoxomycin caused growth suppression and cell death of the MYCN-amplified cell lines examined. Consistent with these data, forced hyper-expression of MYCN in MYCN-amplified IMR5 cells via transfection resulted in growth suppression and the increased expression of several genes known to suppress growth or induce cell death. Furthermore, Epoxomycin as a single agent and its combination with TSA enhance p53 expression in the MYCN-amplified neuroblastoma cell lines. Unexpectedly, co-transfection of TP53 and MYCN in IMR5 cells resulted in high p53 expression but a reduction of MYCN expression. Together our data suggest that either down regulation or hyper-expression of MYCN results in growth inhibition and/or apoptosis of MYCN-amplified neuroblastoma cells. In addition, elevated p53 expression has a suppressive effect on MYCN expression in these cells.

Related Articles

Journal Cover

October 2010
Volume 37 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Torres J, Regan PL, Edo R, Leonhardt P, Jeng EI, Rappaport EF, Ikegaki N and Tang XX: Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas. Int J Oncol 37: 983-991, 2010.
APA
Torres, J., Regan, P.L., Edo, R., Leonhardt, P., Jeng, E.I., Rappaport, E.F. ... Tang, X.X. (2010). Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas. International Journal of Oncology, 37, 983-991. https://doi.org/10.3892/ijo_00000749
MLA
Torres, J., Regan, P. L., Edo, R., Leonhardt, P., Jeng, E. I., Rappaport, E. F., Ikegaki, N., Tang, X. X."Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas". International Journal of Oncology 37.4 (2010): 983-991.
Chicago
Torres, J., Regan, P. L., Edo, R., Leonhardt, P., Jeng, E. I., Rappaport, E. F., Ikegaki, N., Tang, X. X."Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas". International Journal of Oncology 37, no. 4 (2010): 983-991. https://doi.org/10.3892/ijo_00000749